Clinical Trial Update: Treatment of Intermediate-stage Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for treatment of intermediate-stage hepatocellular carcinoma (HCC) is listed, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: HCC | Phase 3 | Status: UNKNOWN